AU738116B2 - Chemokine beta-15 - Google Patents

Chemokine beta-15 Download PDF

Info

Publication number
AU738116B2
AU738116B2 AU63358/96A AU6335896A AU738116B2 AU 738116 B2 AU738116 B2 AU 738116B2 AU 63358/96 A AU63358/96 A AU 63358/96A AU 6335896 A AU6335896 A AU 6335896A AU 738116 B2 AU738116 B2 AU 738116B2
Authority
AU
Australia
Prior art keywords
polypeptide
nucleic acid
polynucleotide
acid molecule
isolated nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU63358/96A
Other languages
English (en)
Other versions
AU6335896A (en
Inventor
Brent L. Kreider
Craig A Rosen
Ying-Fei Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU6335896A publication Critical patent/AU6335896A/en
Priority to AU57980/01A priority Critical patent/AU771475B2/en
Application granted granted Critical
Publication of AU738116B2 publication Critical patent/AU738116B2/en
Priority to AU2004202629A priority patent/AU2004202629A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63358/96A 1996-06-17 1996-06-17 Chemokine beta-15 Ceased AU738116B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU57980/01A AU771475B2 (en) 1996-06-17 2001-08-10 Chemokine beta-15
AU2004202629A AU2004202629A1 (en) 1996-06-17 2004-06-17 Chemokine Beta - 15

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002258507A CA2258507A1 (en) 1996-06-17 1996-06-17 Chemokine beta-15
PCT/US1996/010561 WO1997048807A1 (en) 1996-06-17 1996-06-17 CHEMOKINE β-15

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU57980/01A Division AU771475B2 (en) 1996-06-17 2001-08-10 Chemokine beta-15

Publications (2)

Publication Number Publication Date
AU6335896A AU6335896A (en) 1998-01-07
AU738116B2 true AU738116B2 (en) 2001-09-06

Family

ID=25680722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63358/96A Ceased AU738116B2 (en) 1996-06-17 1996-06-17 Chemokine beta-15

Country Status (7)

Country Link
EP (1) EP0909320A4 (hu)
JP (1) JP2000515733A (hu)
AU (1) AU738116B2 (hu)
CA (1) CA2258507A1 (hu)
HU (1) HUP9903711A3 (hu)
IL (1) IL127551A0 (hu)
WO (1) WO1997048807A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329159B1 (en) 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function

Also Published As

Publication number Publication date
WO1997048807A1 (en) 1997-12-24
HUP9903711A3 (en) 2001-12-28
JP2000515733A (ja) 2000-11-28
EP0909320A1 (en) 1999-04-21
HUP9903711A2 (hu) 2000-03-28
IL127551A0 (en) 1999-10-28
AU6335896A (en) 1998-01-07
EP0909320A4 (en) 2004-12-01
CA2258507A1 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
AU708903B2 (en) Human chemokine polypeptides
AU723891B2 (en) Human chemokine beta-11 and human chemokine alpha-1
US6458349B1 (en) Chemokine β-4 polypeptides
AU713267B2 (en) Human chemokine beta-13
WO1998006839A1 (en) Cd44-like protein
AU733603B2 (en) Chemokine alpha 2
WO1998024908A1 (en) Human chemokine beta-13
US7829293B2 (en) Antibodies to chemokine β-15
WO1998011138A1 (en) Chemokine alpha-4
AU738116B2 (en) Chemokine beta-15
US6537539B2 (en) Immune cell cytokine
AU771475B2 (en) Chemokine beta-15
WO1998007862A9 (en) Chemokine beta-16
US6576445B1 (en) Chemokine α-4
AU2004202629A1 (en) Chemokine Beta - 15
WO1998007862A2 (en) Chemokine beta-16
US20060073573A1 (en) Chemotactic cytokine III
AU753088B2 (en) Human chemokine polypeptides
AU750982B2 (en) Human chemokine beta-11 and human chemokine alpha-1
AU753730B2 (en) Human chemokine beta-13
AU767338B2 (en) Chemokine alpha 2
MXPA98010779A (en) Quiniocina beta
KR20000016743A (ko) 케모카인 베타-15
US20060142199A1 (en) CD-44 like protein
KR20010087423A (ko) 케모카인 베타-15

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)